retatrutide clinical trials news Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation Retatrutide for weight loss: Study
Description
Uncap from the needle

Some patients report temporary changes in urine odor when starting semaglutide or tirzepatide

Benefits of Retatrutide: Reduced liver fat: Studies have demonstrated that retatrutide can significantly reduce liver fat in individuals with obesity and non-alcoholic fatty liver disease (NASH)

Good candidates typically have a BMI over 30, or a BMI of 27 or higher along with one or more weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol

Marked improvements in lipid profile and blood pressure were also observed compared to placebo [81]
Having the additional sales for the Wegovy pill could be particularly valuable as Novo Nordisk tries to build sales momentum for the oral formulation of semaglutide before competition emerges
:max_bytes(150000):strip_icc()/VWH-GettyImages-2247616008-f6337b6fe79748e9894463fef7b147d3.jpg)